Cargando…

Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer

INTRODUCTION: Mutations in known predisposition genes account for only about a third of all multiple-case breast cancer families. We hypothesized that germline mutations in FANCD2, BRIP1/BACH1, LMO4 and SFN may account for some of the unexplained multiple-case breast cancer families. METHODS: The fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Aaron G, Flanagan, James, Marsh, Anna, Pupo, Gulietta M, Mann, Graham, Spurdle, Amanda B, Lindeman, Geoffrey J, Visvader, Jane E, Brown, Melissa A, Chenevix-Trench, Georgia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410737/ https://www.ncbi.nlm.nih.gov/pubmed/16280053 http://dx.doi.org/10.1186/bcr1336

Ejemplares similares

Variation in the RAD51 gene and familial breast cancer
por: Lose, Felicity, et al.
Publicado: (2006)

BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2007)

Correction: BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2008)

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2019)

The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia
por: Marsh, Anna, et al.
Publicado: (2001)

BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
por: Frank, Bernd, et al.
Publicado: (2007)

Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma
por: Murphy, N C, et al.
Publicado: (2008)

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource
por: Mann, Graham J, et al.
Publicado: (2006)

Cell fate takes a slug in BRCA1-associated breast cancer
por: Lindeman, Geoffrey J, et al.
Publicado: (2011)

Sulforaphane (SFN): An Isothiocyanate in a Cancer Chemoprevention Paradigm
por: Ullah, Mohammad Fahad
Publicado: (2015)

capturing the spirit of contemporary neuroscience: sfN lessons for IAN
por: Arunan, M. C.
Publicado: (2010)

Expression profile and prognostic value of SFN in human ovarian cancer
por: Hu, Yi, et al.
Publicado: (2019)

Olaparib Monotherapy for BRIP1-Mutated High-Grade Serous Endometrial Cancer
por: Nakamura, Kohei, et al.
Publicado: (2020)

Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms
por: Pettigrew, Christopher, et al.
Publicado: (2005)

Biochemical Feature of LMO2 Interactome and LMO2 Function Prospect
por: Wang, Wenhao, et al.
Publicado: (2020)

The Mitochondrial Genes BAK1, FIS1 and SFN are Linked with Alterations in Mitochondrial Membrane Potential in Barrett’s Esophagus
por: Phelan, James J., et al.
Publicado: (2018)

Method of Calculating Desynchronization of DVB-T Transmitters Working in SFN for PCL Applications
por: Klincewicz, Karol, et al.
Publicado: (2020)

Loss of the BRCA1-Interacting Helicase BRIP1 Results in Abnormal Mammary Acinar Morphogenesis
por: Daino, Kazuhiro, et al.
Publicado: (2013)

CRISPY-BRED and CRISPY-BRIP: efficient bacteriophage engineering
por: Wetzel, Katherine S., et al.
Publicado: (2021)

LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression
por: Montañez-Wiscovich, ME, et al.
Publicado: (2009)

Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer
por: Song, Honglin, et al.
Publicado: (2007)

Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies
por: Voutsadakis, Ioannis A
Publicado: (2020)

Two tSNPs in BRIP1 are associated with breast cancer during TDT analysis
por: Li, Xuefei, et al.
Publicado: (2021)

Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes
por: D’Elia, Giovanna, et al.
Publicado: (2023)

FANCD2 and DNA Damage
por: Nepal, Manoj, et al.
Publicado: (2017)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

Work through SfN — but Keep Higher Education and K-12 Separate
por: Olivo, Richard F.
Publicado: (2007)

SfN Journals: Two Paths, One Goal: Sharing Strong Science
por: Bernard, Christophe, et al.
Publicado: (2016)

The FANCD2–FANCI complex is recruited to DNA interstrand crosslinks before monoubiquitination of FANCD2
por: Liang, Chih-Chao, et al.
Publicado: (2016)

Bach
por: Alain, Olivier
Publicado: (1977)

Bach
por: Boyd, Malcolm
Publicado: (1985)

Bach
por: Marcel, Luc-André
Publicado: (1961)

Patient-derived xenograft models of breast cancer and their predictive power
por: Whittle, James R, et al.
Publicado: (2015)

Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression
por: Cai, Xiaoyan, et al.
Publicado: (2019)

No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer
por: Campbell, Ian G, et al.
Publicado: (2004)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity
por: ZOU, WEI, et al.
Publicado: (2016)

BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes
por: Gupta, Ishita, et al.
Publicado: (2017)

Helicase-inactivating BRIP1 mutation yields Fanconi anemia with microcephaly and other congenital abnormalities
por: Kamal, Lara, et al.
Publicado: (2020)

Ovarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor gene
por: Ntemou, E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tlnvqtg22fact1rfs94g943m8l